Presentations
Documents
Why Should We Care About NAFLD?
| Date added: | 04/20/2018 |
| Date modified: | 04/20/2018 |
| Filesize: | 256 Bytes |
| Downloads: | 185 |
Oral presentation given by UNEW at the 1st International Conference on Fatty Liver (ICFL), Seville, Spain, 1st - 3rd June 2017
The European NAFLD registry
| Date added: | 04/20/2018 |
| Date modified: | 04/20/2018 |
| Filesize: | 256 Bytes |
| Downloads: | 210 |
Oral presentation given by UNEW at the 1st International Conference on Fatty Liver (ICFL), Seville, Spain, 1st - 3rd June 2017
Adipose tissue expandability, Lipotoxicity and the Metabolic Syndrome
| Date added: | 04/20/2018 |
| Date modified: | 04/20/2018 |
| Filesize: | 5.58 MB |
| Downloads: | 129 |
Oral presentation given by UCAM at the 19th European Congress of Endocrinology (ECE), Satellite Symposium (Aegerion Pharmaceuticals), Lisbon, Portugal, 20th - 23rd May 2017
Hepatic lipotoxicity and mitochondrial dysfunction: impact of adipose tissue inflammation and...
| Date added: | 04/20/2018 |
| Date modified: | 04/20/2018 |
| Filesize: | 256 Bytes |
| Downloads: | 169 |
"Hepatic lipotoxicity and mitochondrial dysfunction: impact of adipose tissue inflammation and insulin resistance"
Oral presentation given by CNR at the 51st European Society for Clinical Investigation (ESCI) conference, Genoa, Italy, 17th - 19th May 2017
Metabolic syndrome and NAFLD
| Date added: | 04/20/2018 |
| Date modified: | 04/20/2018 |
| Filesize: | 256 Bytes |
| Downloads: | 175 |
Oral presentation given by CNR at the Tuscan Hepatologists meeting, Italy, 10th - 11th May 2017
Serum phosphatidylglycerols (PG) are correlated with human obesity, gut dysbiosis, and are induced..
| Date added: | 04/20/2018 |
| Date modified: | 04/20/2018 |
| Filesize: | 256 Bytes |
| Downloads: | 162 |
"Serum phosphatidylglycerols (PG) are correlated with human obesity, gut dysbiosis, and are induced by endotoxin"
Poster presentation given by ICAN at the Keystone Symposium “Gastrointestinal Control of Metabolism”, Copenhagen, Denmark, 9th - 13th May 2017
Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin...
| Date added: | 03/13/2018 |
| Date modified: | 03/13/2018 |
| Filesize: | 256 Bytes |
| Downloads: | 317 |
"Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin Resistance and Liver Histology in Patients with NASH"
Oral presentation given by CNR at the 5th EASD-NAFLD Study Group meeting, Gothenburg, Sweden, 8th - 9th May 2017
The role of genetic assessments in Non-Alcoholic Fatty Liver Disease
| Date added: | 03/13/2018 |
| Date modified: | 03/13/2018 |
| Filesize: | 6.91 MB |
| Downloads: | 281 |
Oral presentation given by UNEW at the 2nd International Workshop on NASH Biomarkers, Washington DC, USA, 5th - 6th May 2017
Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin...
| Date added: | 03/13/2018 |
| Date modified: | 03/13/2018 |
| Filesize: | 256 Bytes |
| Downloads: | 272 |
"Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin Resistance and Liver Histology in Patients with NASH"
Oral presentation given by CNR at the European Group for the study of Insulin Resistance (EGIR) meeting, Dublin, Ireland, 4th - 6th May 2017
Increased hepatic glucose production and insulin resistance in subjects with Non-Alcoholic Fatty...
| Date added: | 03/10/2018 |
| Date modified: | 03/10/2018 |
| Filesize: | 2.19 MB |
| Downloads: | 171 |
"Increased hepatic glucose production and insulin resistance in subjects with Non-Alcoholic Fatty Liver Disease is associated to increased plasma concentrations of gluconeogenic amino acids"
Poster presentation given by UNITO & CNR at the EASL International Liver Congress (ILC), Amsterdam, Netherlands, 19th - 23rd April 2017
